IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q2 2025 Holdings

Filed 2025-07-10 | 2 holdings | $15.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics, Inc.(KYTX)Common Stock501976104$13.9M4,523,92487.2%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$2.0M1,798,16312.8%